Search Count: 29
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L141R With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: DMS, V2M, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-07
Ligands: DMS, V2M, NA
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant N142P With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-07
Ligands: V2M
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L50F With Nirmatrelvir Captured In Two Conformational States
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: DMS, 4WI, NA, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-07
Ligands: DMS, 4WI, NA, CL
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp4/5 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp5/6 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp6/7 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp7/8 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp8/9 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp10/11 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 4/5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL, DMS
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 5/6
Organism: Severe acute respiratory syndrome coronavirus 2, Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2, Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL, DMS
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 7/8
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: EDO, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: EDO, GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 8/9
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 9/10
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 10/11
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 12/13
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 13/14
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 15/16
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Hiv-1 Protease Nl4-3 Wt In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017, SO4